Deborah Birx
Directeur Général chez ARMATA PHARMACEUTICALS, INC.
Fortune : 2 M $ au 30/04/2024
Postes actifs de Deborah Birx
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 11/07/2023 | - |
| Directeur Général | 11/07/2023 | - | |
Nanolive SA
 Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Deborah Birx
Anciens postes connus de Deborah Birx
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INNOVIVA, INC. | Directeur/Membre du Conseil | 09/03/2021 | 10/07/2023 |
| Independent Dir/Board Member | 09/03/2021 | 10/07/2023 |
Formation de Deborah Birx
| Houghton College | Undergraduate Degree |
| Pennsylvania State University College of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Suisse | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Nanolive SA
Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Health Technology |
- Bourse
- Insiders
- Deborah Birx
- Expérience
